All filters
Abstracts
Clients’ satisfaction with HIV treatment services in Bamenda, Cameroon: a cross-sectional study
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Switching Efavirenz-containing and Lopinavir/ritonavir-containing regimen to Dolutegravir-based regimen: cardiovascular disease risk lipid profile analysis in an Ukrainian HIV-infected cohort
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
HIV drug resistance and distribution of genotypes among ART-naĂŻve patients in Uzbekistan
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Advance results of the second national monitoring of HIV drug resistance in Uzbekistan
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
The model of individual gorecast of Fibrosis progression in time depending on the age, activity index and gender
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Hospital pharmacists’ intervention in antiretroviral (ARV) medications
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Usability of a Mobile Health Application (“APP”) on older HIV-Infected Patients: An emerging tool for care, education and prevention
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
e-Health solution characteristics for PLHIV: a Portuguese experience
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Current status of HIV: the importance of comorbidities. Do we have to worry about the quality of life of our HIV patients?
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
HIV and Ageing – Primary and secondary prevention of coronary artery disease among People Living with HIV
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
Country specific factors determine the quality of life among people with HIV in two western European countries
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
An online survey of the quality of life in patients with HIV-infection in Krasnodar
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
HIV-related stigma and quality of life outcomes among people living with HIV in the Netherlands
Presented at:
European Workshop on Healthy Living with HIV 2019
Abstracts
The relationship between the migration status and the Health-Related Quality of Life (HRQoL) of people living with HIV: a study on the Swedish InfcareHIV cohort from 2011 to 2017
Presented at:
European Workshop on Healthy Living with HIV 2019
Videos
Managing Complex Patients - US | Charles Flexner
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Monica Gandhi
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Sharon Walmsley
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Daniel Kuritzkes
Presented at:
Managing Complex HIV Patients 2020- US Edition
Videos
Managing Complex Patients - US | Michael Kozal
Presented at:
Managing Complex HIV Patients 2020- US Edition
Abstracts
An assessment of the effects of dolutegravir on gene expression and levonorgestrel clearance in human hepatocytes in vitro
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Cobicistat (COBI)-boosted Protease Inhibitors (PIs) plasma and intracellular (IC) pharmacokinetics (PK) in nicotine users
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Glecaprevir/pibrentasvir pharmacokinetics in HCV/HIV patients co-administered with antiretroviral drugs
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The valproic acid – dolutegravir drug-drug interaction is based on displacement of protein binding and unlikely to be clinically relevant
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Valproic acid co-administration is not associated with lower non-dolutegravir antiretrovirals’ exposures
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019